SmartSpot Quality
SmartSpot Quality, founded in 2010 as a research program at the University of Witwatersrand, has evolved into a leading South African private company. Specializing in molecular testing controls, SmartSpot meets the stringent quality needs of TB molecular laboratories worldwide. The company holds an exclusive license to patented technology developed by the Department of Molecular Medicine and Haematology and the Centre of Excellence for Biomedical TB Research. Over the past decade, SmartSpot has expanded globally, serving Ministries of Health, Clinical Trial Units, and private laboratories in 30 countries. They are renowned as the largest commercial supplier of molecular TB controls and offer companion diagnostics for TB, HIV, SARS-CoV-2, with plans to include MRSA and HCV diagnostics soon. Dean Sher, CEO and Co-Founder, participated in the program 2013.